Program of rehabilitative exercise and education to avert vascular events after non-disabling stroke or transient ischemic attack (PREVENT Trial): a multi-centred, randomised controlled trial

Marilyn MacKay-Lyons, Gordon Gubitz, Nicholas Giacomantonio, Howard Wightman, David Marsters, Kara Thompson, Chris Blanchard, Gail Eskes, Marianne Thornton, Marilyn MacKay-Lyons, Gordon Gubitz, Nicholas Giacomantonio, Howard Wightman, David Marsters, Kara Thompson, Chris Blanchard, Gail Eskes, Marianne Thornton

Abstract

Background: Despite lack of outward signs, most individuals after non-disabling stroke (NDS) and transient ischemic attack (TIA) have significant cardiovascular and cerebrovascular disease and are at high risk of a major stroke, hospitalization for other vascular events, or death. Most have multiple modifiable risk factors (e.g., hypertension, physical inactivity, hyperlipidaemia, diabetes, tobacco consumption, psychological stress). In addition, accelerated rates of depression, cognitive decline, and poor quality of sleep have been reported following TIA, which correlate with poor functional outcomes and reduced quality of life. Thus, NSD and TIA are important warning signs that should not be overlooked. The challenge is not unlike that facing other 'silent' conditions - to identify a model of care that is effective in changing people's current behaviors in order to avert further morbidity.

Methods/design: A single blind, randomized controlled trial will be conducted at two sites to compare the effectiveness of a program of rehabilitative exercise and education versus usual care in modifying vascular risk factors in adults after NDS/TIA. 250 adults within 90 days of being diagnosed with NDS/TIA will be randomly allocated to a 12-week program of exercise and education (PREVENT) or to an outpatient clinic assessment and discussion of secondary prevention recommendations with return clinic visits as indicated (USUAL CARE). Primary outcome measures will include blood pressure, waist circumference, 12-hour fasting lipid profile, and 12-hour fasting glucose/hemoglobin A1c. Secondary measures will include exercise capacity, walking endurance, physical activity, cognitive function, depression, goal attainment and health-related quality of life. Outcome assessment will be conducted at baseline, post-intervention, and 6- and 12-month follow-ups. Direct health care costs incurred over one year by PREVENT versus USUAL CARE participants will also be compared. Ethical approval for the trial has been obtained from the relevant Human Research Ethics Boards.

Discussion: Whether timely delivery of an adapted cardiac rehabilitation model is effective in attaining and maintaining vascular risk reduction targets in adults after NDS/TIA is not yet known. We anticipate that the findings of this trial will make a meaningful contribution to the knowledge base regarding secondary stroke prevention.

Trial registration: ClinicalTrials.gov NCT00885456.

Figures

Figure 1
Figure 1
Flow chart outlining the study protocol.

References

    1. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, Sherman DG. Transient ischemic attack - proposal for a new definition. New Engl J Med. 2002;347:1713–1716. doi: 10.1056/NEJMsb020987.
    1. Hankey GJ. Redefining risks after TIA and minor ischemic stroke. Lancet. 2005;365:2065–2066. doi: 10.1016/S0140-6736(05)66713-X.
    1. Rothwell PM, Buchan A, Johnston SC. Recent advances in management of transient ischemic attacks and minor ischemic strokes. Lancet Neurol. 2006;5:323–331. doi: 10.1016/S1474-4422(06)70408-2.
    1. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901–2906. doi: 10.1001/jama.284.22.2901.
    1. Kernan WN, Viscoli CM, Brass LM, Makuch RW, Sarrel PM, Roberts RS, Gent M, Rothwell P, Sacco RL, Lui R-C, Boden-Albaba B, Horwitz RI. The Stroke Prognosis Instrument II (SPI-II): a clinical prediction instrument for patients with transient ischemic attack and nondisabling stroke. Stroke. 2000;31:456–462.
    1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–1757. doi: 10.1016/S0140-6736(06)68770-9.
    1. Spieler J-F, de Pouvourville G, Amarenco P. Cost of a recurrent vs. cost of first-ever stroke over an 18-month period. Eur J Neurol. 2003;10:621–624. doi: 10.1046/j.1468-1331.2003.00665.x.
    1. Hankey GJ, Amrozik JK, Broadhurst RJ, Forbes S, Anderson CS. Long-term disability after first-ever stroke and related prognostic factors in the Perth Community Stroke Study, 1989-1990. Stroke. 2002;33:1034–1040. doi: 10.1161/01.STR.0000012515.66889.24.
    1. Wolf PA, Clagett GP, Easton JD, Goldstein LB, Gorelick PB, Kelly-Hayes M, Sacco RL, Whisnant JP. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the stroke council of the American Heart Association. Stroke. 1999;30:1991–1994.
    1. Roth E. Heart disease in patients with stroke. Part 1: Classification and prevalence. Arch Phys Med Rehabil. 1993;74:752–760. doi: 10.1016/0003-9993(93)90038-C.
    1. Adams RJ, Chimowitz MI, Alpert JS, Awad IA, Cerqueria MD, Fayad P. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation. 2003;108:1278–1290. doi: 10.1161/.
    1. Gordon NF, Gulanick M, Costa F, Fletcher GF, Franklin BA, Roth EJ, Shephard T. Physical activity and exercise recommendations for stroke survivors. An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical Activity, and Metabolism; and the Stroke Council. Circulation. 2004;109:2031–2041. doi: 10.1161/01.CIR.0000126280.65777.A4.
    1. Allen CL, Bayraktutan U. Risk factors for stroke. Int J Stroke. 2008;3:105–116. doi: 10.1111/j.1747-4949.2008.00187.x.
    1. Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JNE, Warlow CP, Mehta Z. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischemic attack. lancet. 2005;366:29–36. doi: 10.1016/S0140-6736(05)66702-5.
    1. Hill MD, Yiannakoulias N, Jeerakathi T, Tu JV, Svenson LW, Schopflocher DP. The high risk of stroke immediately after transient ischemic attack. A population-based study. Neurology. 2004;62:2015–2020.
    1. Gorelick PB. Stroke prevention therapy beyond antithrombotics: Unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. Stroke. 2002;33:862–875. doi: 10.1161/hs0302.103657.
    1. Adams RJ, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Sacco RL, Schwamm LH. American Heart Association; American Stroke Association. Update on the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008;39:1647–1652. doi: 10.1161/STROKEAHA.107.189063.
    1. Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta analyses. Stroke. 2003;34:2475–2481. doi: 10.1161/01.STR.0000091843.02517.9D.
    1. Lu M, Ye W, Adami HO, Weiderpass E. Prospective study of body size and risk for stroke amongst women below age 60. J Intern Med. 2006;260:442–450. doi: 10.1111/j.1365-2796.2006.01706.x.
    1. Walker SP, Rimm EB, Ascherio A, Kawachi I, Stampfer MJ, Willett WC. Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol. 1996;144:1143–1150.
    1. MacKay-Lyons M, Makrides L. Longitudinal changes in exercise capacity after stroke. Arch Phys Med Rehabil. 2004;85:1608–1612. doi: 10.1016/j.apmr.2004.01.027.
    1. Paul SL, Thrift AG. Control of hypertension 5 years after stroke in the North East Melbourne Stroke Incidence Study. Hypertension. 2006;48:260–265. doi: 10.1161/01.HYP.0000230610.81947.04.
    1. Iso H, Jacobs DRJ, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med. 1989;320:904–910. doi: 10.1056/NEJM198904063201405.
    1. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469–480. doi: 10.1111/j.1464-5491.2006.01858.x.
    1. Liou CW, Tan TY, Lin TK, Wang PW, Yip HK. Metabolic syndrome and three of its components as risk factors for recurrent ischemic stroke presenting as large-vessel infarction. Eur J Neurol. 2008;15:802–809. doi: 10.1111/j.1468-1331.2008.02181.x.
    1. Bokura H, Yamaguchi S, Iijima K, Nagai A, Oguro H. Metabolic syndrome is associated with silent ischemic brain lesions. Stroke. 2008;39:1607–1609. doi: 10.1161/STROKEAHA.107.508630.
    1. Mouradian MS, Majumdar SR, Senthilselvan A, Khan K, Shuaib A. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke. 2002;33:1656–1659. doi: 10.1161/01.STR.0000017877.62543.14.
    1. Kopunek SP, Michael KM, Shaughnessy M, Resnick B, Nahm E-S, Whitall J, Goldberg A, Macko RF. Cardiovascular risk in survivors of stroke. Am J Prevent Med. 2007;32:408–412. doi: 10.1016/j.amepre.2007.01.021.
    1. MacKay-Lyons M, MacDonald C, Howlett J. Metabolic syndrome and its components in individuals undergoing rehabilitation after stroke. J Neurol Phys Ther. 2009;33:189–194.
    1. Croquelois A, Bogousslavsky J. Risk awareness and knowledge of patients with stroke: results of a questionnaire survey 3 months after stroke. J Neurol Neurosurg Psychiat. 2006;77:726–728. doi: 10.1136/jnnp.2005.078618.
    1. Kallio V, Hamalainen H, Hakkila J, Luurila OJ. Reduction in sudden deaths by a multifactorial intervention programme after acute myocardial infarction. Lancet. 1979;November 24th:1091–1094. doi: 10.1016/S0140-6736(79)92502-9.
    1. Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, Williams PT, Johnstone IM, Champagne MA, Krauss RM. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP) Circulation. 1994;89:975–990.
    1. Jolliffe JA, Rees K, Taylor RS, Thompson D, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease. Cochrane Database of Systematic Reviews. 2001. p. Art. No.: CD001800.
    1. Brunner EJ, Rees K, Ward K, Burke M, Thorogood M. Dietary advice for reducing cardiovascular risk. Cochrane Database of Systematic Reviews. 2007. p. Art. No.: CD002128.
    1. Deakin T, McShane CE, Cade JE, Williams RD. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 2005. p. Art. No.: CD003417.
    1. Gæde P, Vedel P, Larsen N, Jensen G, Parving H-H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–393.
    1. Orzano AJ, Scott JG. Diagnosis and treatment of obesity in adults: an applied evidence-based review. J Am Board Fam Pract. 2004;17:359–369. doi: 10.3122/jabfm.17.5.359.
    1. Van Gaal LF, Mertens IL, Ballaux D. What is the relationship between risk factor reduction and degree of weight loss? Europ Heart J. 2000;7(Suppl L):L21–26.
    1. Lancaster T, Stead LF. Self-help interventions for smoking cessation. Cochrane Database of Systematic Reviews. 2005. p. Art. No.: CD001118.
    1. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone JA, Thompson DR, Oldridge N. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004;116:682–692. doi: 10.1016/j.amjmed.2004.01.009.
    1. Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, Thompson PD, Williams MA, Lauer MS. for the American Heart Association; Council on Clinical Cardiology (Subcommittee on Exercise CR and Prevention); Council on Nutrition PA and Metabolism (Subcommittee on Physical Activity); Rehabilitation AAoCaP. Cardiac rehabilitation and secondary prevention of coronary heart disease: An American Heart Association Scientific Statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in Collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2005;111:369–376. doi: 10.1161/01.CIR.0000151788.08740.5C.
    1. Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S. Effects of exercise training on older patients with major depression. Arch Intern Med. 1999;159:2349–2356. doi: 10.1001/archinte.159.19.2349.
    1. Lewin B, Robertson IH, Cay EL, Irving JB, Campbel M. Effects of self-help post-myocardial infarction rehabilitation on psychological adjustment and use of health services. Lancet. 1992;339:1036–1040. doi: 10.1016/0140-6736(92)90547-G.
    1. Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci. 2003;14:125–130. doi: 10.1111/1467-9280.t01-1-01430.
    1. Gunstad J, MacGregor K, Paul R, Poppas A, Jefferson A, Todaro J, Cohen R. Cardiac rehabilitation improves cognitive performance in older adults with cardiovascular disease. J Cardiopulm Rehabil. 2005;25:173–175. doi: 10.1097/00008483-200505000-00009.
    1. Angevaren M, Aufdemkampe G, Verhaar HJJ, Aleman A. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database of Systematic Reviews. 2008. p. Art. No.: CD005381.
    1. Kramer AF, Erickson KI. Capitalizing on cortical plasticity: influence of physical activity on cognition and brain function. Trends Cogn Sci. 2007;11:342–348. doi: 10.1016/j.tics.2007.06.009.
    1. Bakker FC, Klijn CJM, van der Grond J, Kappelle LJ, Jennekens-Schinkel A. Cognition and quality of life in patients with carotid artery occlusion. A follow-up study. Neurology. 2004;62:2230–2235.
    1. Anson O, Paran E. Hypertension and cognitive functioning among the elderly: an overview. Am J Therapeutics. 2005;12:359–365. 10.1097/01.mjt.00001= 09849.55405.48.
    1. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. Depressive symptoms, vascular disease and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psych. 2006;63:273–279. doi: 10.1001/archpsyc.63.3.273.
    1. Jorge RE, Robinson RG, Arndt S, Starkstein S. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry. 2003;160:1823–1829. doi: 10.1176/appi.ajp.160.10.1823.
    1. Hackam DG, Spence D. Combining multiple approaches for the secondary prevention of vascular events after stroke. A quantitative modeling study. Stroke. 2007;38:1881–1885. doi: 10.1161/STROKEAHA.106.475525.
    1. Tanne D, Tsabari R, Chechik O, Toledano A, Orion D. Improved exercise capacity in patients after minor ischemic stroke undergoing a supervised exercise training program. Israel Med Assoc J. 2008;10:113–116.
    1. Sit JW, Yip VYB, Ko S, Gun APC, Lee JSH. A quasi-experimental study on a community-based stroke prevention programme for clients with minor stroke. J Clin Nurs. 2007;16:272–281. doi: 10.1111/j.1365-2702.2005.01522.x.
    1. Lennon O, Carey A, Gaffney N, Stephenson J. A pilot randomized controlled trial to evaluate the benefit of the cardiac rehabilitation paradigm for the non-acute ischemic stroke population. Clin Rehabil. 2008;22:125–133. doi: 10.1177/0269215507081580.
    1. Tang A, Closson V, Marzolini S, Oh P, McIlroy W, Brooks D. Cardiac rehabilitation after stroke: need and opportunity. J Cardiopulm Rehabil Prev. 2009;29:97–104.
    1. ESPRIT Study Group. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006;367:1665–1673. doi: 10.1016/S0140-6736(06)68734-5.
    1. Markus HS, Droste DW, Kaps M. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation. 2005;111:2233–2240. doi: 10.1161/01.CIR.0000163561.90680.1C.
    1. Bond R, Rerkasem K, Rothwell PM. A systematic review of the risks of carotid endarterectomy in relation to the clinical indication and the timing of surgery. Stroke. 2003;34:2290–2301. doi: 10.1161/.
    1. Lindsay P, Bayley M, Hellings C, Hill MD, Woodbury E, Philips S. Canadian best practice recommendations for stroke care (updated 2008) Can Med Assoc J. 2008;179:S1–S25. doi: 10.1503/cmaj.081148.R2.
    1. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein lB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Circulation. 2006;113:e409–e449.
    1. Myint P, Welch A, Bingham S, Luben R, Wareham N, Khaw K-T. Smoking predicts long-term mortality in stroke: The European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study. Preventive Med. 2006;42:128–131. doi: 10.1016/j.ypmed.2005.11.014.
    1. Brott T, Adams HP, Olinger CP. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864–870.
    1. American College of Sports Medicine. Guidelines for Exercise Testing and Prescription. 7. Baltimore: Lippincoott Williams and Wilkins; 2005.
    1. Environmental Supports for Physical Activity Questionnaire. Prevention Research Center.
    1. Üstun TB, Chatterji S, Bickenbach J, Kostanjsek N, Schneider M. The International Classification of Functioning, Disability and Health: a new tool for understanding disability and health. Disabil Rehabil. 2003;25:565–571.
    1. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves JE, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood Pressure Measurement in Humans: A statement from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697–716. doi: 10.1161/01.CIR.0000154900.76284.F6.
    1. Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, Kahn R. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr. 2007;85:1197–1202.
    1. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: association between self-report disability and prediction of mortality and nursing home admission. J Gerontol Med Sci. 1994;49:M85–94.
    1. Crapo R, Enright PL, Zeballos R. ATS statement: guidelines for the six-minute walk test. Am Thoracic Soc. 2002;166:111–117.
    1. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Med. 2003;35:1381–1395.
    1. Michielson HJ, De Vries J, Van Heck GL. Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment Scale. J Psychosom Res. 2003;54:345–353. doi: 10.1016/S0022-3999(02)00392-6.
    1. Nasreddine ZS, Phillips NA, Bedirian V, Whitehead V. The Montreal Cognitive Assessment (MoCA): A brief screening tool for mild cognitive impairment. J Am Geriat Soc. 2005;53:695–699. doi: 10.1111/j.1532-5415.2005.53221.x.
    1. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index (PSQI): A new instrument for psychiatric research and practice. Psychiatry Res. 1989;28:193–213. doi: 10.1016/0165-1781(89)90047-4.
    1. Ware JE, Sherbourne CD. The MOS 36-Item Short Form Survey (SF-36®): 1. conceptual framework and item selection. Med Care. 1992;30:473–483. doi: 10.1097/00005650-199206000-00002.
    1. Turner-Stokes L. Goal attainment scaling (GAS) in rehabilitation: a practical guide. Clin Rehabil. 2009;23:362–370. doi: 10.1177/0269215508101742.
    1. Lindsay P, Silver FL, Gladstone DJ. Canadian Stroke Quality of Care Study V: Secondary Prevention. Institute of Clinical Evaluative Sciences, Toronto, Ontario; Ontario Stroke Strategy-Ontario Ministry of Health & Long Term Care; Canadian Stroke Network, Ottawa Ontario. 2006.
    1. Barnett E, Anderson T, Blosnich J, Halverson J, Novak J. Promoting cardiovascular health from individual goals to social environmental change. Am J Prev Med. 2005;29:107–112. doi: 10.1016/j.amepre.2005.07.036.
    1. Baranowski T, Anderson C, Carmack C. Mediating variable framework in physical activity interventions. How are we doing? How might we do better? Am J Prev Med. 1998;15:266–297. doi: 10.1016/S0749-3797(98)00080-4.
    1. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377–381.
    1. Ilarraza H, Myers J, Kottman W, Rickli H, Dubach P. An evaluation of training responses using self-regulation in a residential rehabilitation program. J Cardiopulm Rehabil. 2004;24:27–33. doi: 10.1097/00008483-200401000-00006.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi